Mazzaschi, Francesca, Sivell, Stephanie ![]() ![]() |
Abstract
Between 2014 and 2016, 11,725 people were diagnosed with brain tumours. Standard treatment consists of surgery, radiotherapy and chemotherapy. Treatment of high-grade gliomas, which account for 70-80% of primary brain tumours, is conducted with palliative intent. High-grade glioma is accompanied by an array of debilitating symptoms. Symptom burden is heightened by the effects of radiotherapy or chemoradiotherapy. The symptoms faced by the patient, especially those of a cognitive and psychological nature, can alter the patient’s relationships with those around them and is in turn detrimental to quality of life. Identifying cognitive deficits as early as possible is essential to support the patient, and to help those around them emotionally adjust. It also provides a more in depth understanding of the patient’s needs, and possibly allow access to appropriate neurorehabilitation.
Item Type: | Conference or Workshop Item (Poster) |
---|---|
Status: | Published |
Schools: | Medicine Marie Curie Palliative Care Research Centre (MCPCRC) |
Publisher: | SAGE Publications |
ISSN: | 0269-2163 |
Last Modified: | 24 Jul 2023 13:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/160666 |
Actions (repository staff only)
![]() |
Edit Item |